Search the Newsreel

Lido Advisors LLC Trims Position in Take-Two Interactive Software, Inc. $TTWO

Lido Advisors LLC reduced its stake in Take-Two Interactive Software, Inc. by 67.6% in the first quarter, now owning 2,149 shares worth $424,000. Other institutional investors also adjusted their holdings, with hedge funds and institutions collectively owning 95.46% of the company's stock. Insider selling …

Take-Two Interactive Software Inc. (TTWO) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live quotes and charts for Take-Two Interactive Software Inc. (TTWO) stock, showing its current price of $243.51 with a slight increase of $0.59 (0.24%). It notes that analyst ratings and earnings information are not currently available for the company. The page …

Take-Two Interactive Software Inc. stock underperforms Friday when compared to competitors

Take-Two Interactive Software Inc. (TTWO) stock fell by 1.82% on Friday, closing at $242.92, despite a positive trading session for the broader market. The S&P 500 Index and Dow Jones Industrial Average both saw gains. The company's stock is currently 8.66% below its 52-week …

Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline

Takeda Pharmaceutical, Japan's leading pharmaceutical company, is poised for top-line growth driven by a refreshed late-stage pipeline. The company has strategically diversified away from the stagnant Japanese market through significant acquisitions, notably the $57 billion purchase of Shire Plc in 2019, which expanded its …

Take-Two Interactive Software, Inc. $TTWO Shares Acquired by Sei Investments Co.

Sei Investments Co. increased its stake in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) by 24.9% in the first quarter, now owning 79,679 shares valued at $15.74 million. Other institutional investors also adjusted their positions in TTWO, with significant purchases from firms like Davis R M …

California State Teachers Retirement System Has $59.26 Million Stock Position in Take-Two Interactive Software, Inc. $TTWO

The California State Teachers Retirement System (CalSTRS) reduced its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 2.0% in the first quarter, selling 6,186 shares but still holding 300,041 shares valued at approximately $59.26 million. Institutional investors collectively own 95.46% of Take-Two's stock, while corporate …

Takeda Pharmaceutical (NYSE:TAK) Posts Quarterly Earnings Results, Beats Expectations By $0.31 EPS

Astaka Holdings Limited Provides Consolidated Earnings Guidance for the Six Month Financial Period Ended 30 June 2026

Takeda (TSE:4502) Stock Struggles To Convert Revenue Growth Into Lasting Profit

Take-Two Interactive Software (TTWO) Projected to Announce Quarterly Earnings on Friday

Take-Two Interactive Software (TTWO) is expected to announce its Q1 2027 earnings after market close on Friday, August 7th, with analysts projecting earnings of $0.327 per share and revenues of $1.403 billion. The stock opened at $247.43, near its 12-month high, and holds a …

Takeda Pharmaceutical Maintained at "Neutral" by Major U.S. Securities Firm, Target Price Raised to ¥5,800

A major U.S. securities firm maintained its "Neutral" rating on Takeda Pharmaceutical but raised its target price to ¥5,800 following the company's April-June 2026 quarter results. While revenue increased due to a weaker yen, net profit declined due to higher SG&A and R&D expenses, …

Investors Heavily Search Take-Two Interactive Software, Inc. (TTWO): Here is What You Need to Know

Take-Two Interactive (TTWO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of this publisher of …

Pak Tak International Limited Revenue Breakdown – HKEX:2668

Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda

Keros Therapeutics, Inc. LEXINGTON, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of …

STAK Stock Whipsaws As Traders Focus On Volatile Breakout

STAK Inc. stock is exhibiting extreme volatility, having surged from $1 to over $12 and then pulling back, attracting momentum traders. The stock is currently consolidating within a tight range, suggesting a potential breakout. Despite modest fundamentals, the price action and high trading volume …

STAK Stock Slides Off Spike As Traders Watch Support

STAK Inc. stock has experienced a significant retracement after a rapid spike to an intraday high of $12, now trading around $2.78. This behavior is characteristic of a low-float squeeze followed by a fade, with traders monitoring key support and resistance levels. While the …

STAK Stock Pulls Back As Volatile Rally Cools

STAK Inc. experienced a significant rally followed by a sharp pullback, now consolidating between $2.50 and $2.85. The stock initially surged on news of an AI partnership expansion but has since unwound much of its gains, attracting active traders due to its high volatility. …

STAK|STAK|Price:2.640|Chg%:+0.210

This article provides real-time quotes, trading strategies, and related analysis for STAK (STAK Inc.), a holding company specializing in oilfield production and maintenance equipment. The stock experienced a significant -13.79% change today, although it has shown a +420.24% increase over the last six months. …

STAK Stock Whipsaws After Parabolic Spike, Volatility Draws Day Traders

STAK Inc. stock experienced a significant whipsaw effect, soaring from $1.23 to $12 before settling back into the $2-$3 range. This extreme volatility, driven by an AI platform partnership announcement, has attracted day traders who are now watching for consolidation between $2.60 and $3.05. …

STAK Stock Whipsaws As Traders Target High-Volatility Setup

STAK Inc. stock is exhibiting high volatility, swinging significantly from a $12 spike to the low $2s, making it a target for traders seeking sharp breakouts and breakdowns. Despite its rollercoaster price action, the company shows about $10M in working capital and a low …

Takeda Pharmaceutical Q1 Earnings Call Highlights

Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut Takeda Pharmaceutical (NYSE:TAK) said its first-quarter fiscal 2026 results were in line with its full-year outlook as growth from core brands and newer products largely offset expected declines in its mature portfolio. Revenue …

Earnings call transcript: Takeda Q1 2026 results show steady growth, stock slips premarket

Takeda Pharmaceutical reported Q1 2026 results indicating steady growth, with revenue reaching JPY 1.22 trillion, a 10.2% increase at actual exchange rates, though declining 0.5% at constant currency. Despite core EPS falling due to prior-year tax benefits, the company maintained its full-year guidance and …

Takeda Pharmaceutical (NYSE: TAK) Q1 2026 revenue ¥1.22T, EPS ¥71.65

Takeda Pharmaceutical Company Limited reported consolidated IFRS results for Q1 2026, with revenue reaching ¥1.22 trillion, a 10.2% year-on-year increase primarily due to Japanese yen depreciation. Despite increased revenue and operating profit, net profit attributable to owners declined by 8.9% to ¥113.2 billion, resulting …

Take-Two Interactive Software, Inc. $TTWO Shares Acquired by Amundi

Amundi increased its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 38.1% in the first quarter, now owning 1.35% of the company's stock valued at $492.56 million. Other institutional investors have also adjusted their holdings, while insiders have sold a significant amount of shares. Analysts …

Takeda Pharmaceutical Company Limited bestätigt Gewinnprognose für das Geschäftsjahr 2026

Takeda Pharmaceutical Co cuts FY26 adj EPS to $2.96, sales to $29.1B

Karnataka Bank Q4 Results: Unaudited financials released

Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

Solid first quarter performance broadly in line with guidance, underpinned by resilient demand across core in-line brands Commercial execution and late-stage pipeline investments on schedule, including first approval for ORZEYFULTM (oveporexton) in China, setting the foundation for next wave of medicines No change to …

Should Take-Two’s Officer Liability Shield Proposal Reshape How TTWO Investors View Governance and Performance Risk?

At its September 17, 2026 Annual Meeting, Take-Two Interactive Software proposed amending its Restated Certificate of Incorporation to limit certain officers' liability in line with Delaware law, mainly shielding them from monetary damages in direct shareholder suits while retaining accountability for loyalty breaches and …

Karnataka discusses Takeda GCC expansion, innovation partnerships

Karnataka officials held discussions with Takeda Pharmaceutical leaders regarding the expansion of their Global Capability Centre (GCC) in Bengaluru. The talks focused on leveraging Karnataka's strong biotechnology and medtech ecosystems for digital transformation, research, and product development, including AI-driven drug discovery. Karnataka pledged continued …

Lazard Asset Management LLC Grows Stake in Take-Two Interactive Software, Inc. $TTWO

Lazard Asset Management LLC significantly increased its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 111.1% in the first quarter, now owning 213,026 shares valued at $42.1 million. Other institutional investors like Norges Bank and AQR Capital also expanded their positions, bringing institutional ownership to …

First Trust Advisors LP Buys 46,766 Shares of Take-Two Interactive Software, Inc. $TTWO

First Trust Advisors LP increased its stake in Take-Two Interactive Software, Inc. by 57.3% in the first quarter, purchasing an additional 46,766 shares to own a total of 128,452 shares valued at $25.37 million. This move is part of broader institutional investor activity, with …

Take Two Interactive Software (TTWO) Could Be 11% Undervalued After Officer Exculpation Proposal

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Take-Two Interactive Software (TTWO) has put a proposed Officer Exculpation Amendment on the agenda for its September 17, 2026 shareholder meeting, focusing on …

TTWO|Take-Two Interactive Software Inc|Price:247.570|Chg%:+3.620

This article provides a comprehensive stock analysis of Take-Two Interactive Software Inc (TTWO) by TradingKey, highlighting its healthy fundamentals, significant growth potential, and "fairly valued" status within the Software & IT Services industry. The stock has high institutional ownership and analyst ratings indicating a …

Karnataka Bank Q1 profit jumps 43% as asset quality improves

VAKIF MENKUL KIYMET YATIRIM ORTAKLIĞI A.Ş.(VKFYO) Özel Durum Açıklaması (Genel) 29 Temmuz 2026